SCHEMBL11895063

SCHEMBL11895063

O=C(O)c1cc(Cl)nc2ccc3nn(-c4cccc(F)c4)nc3c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 1/20 0.40
▸ NOTUM Q6P988 1/20 0.39
▸ PKM P14618 1/20 0.38
▸ DHODH Q02127 3/20 0.35
▸ MAPT P10636 5/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ GRIK1 P39086 1/20 0.34
▸ KMT2A Q03164 2/20 0.33
▸ MAPK14 Q16539 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33
▸ ADORA2A P29274 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11894876 0.88 PARP1 (0.48) PARP1PKMMAPTKDM4EKMT2A
SCHEMBL11894766 0.87 KDM4E (0.45) PARP1MAPTKDM4EMAPK1KMT2A
SCHEMBL11895012 0.84 PARP1 (0.40) PARP1NOTUMDHODHMAPTKDM4E
SCHEMBL11894730 0.82 MAPT (0.42) PARP1NOTUMPKMDHODHMAPT
SCHEMBL11894630 0.82 GAA (0.55) DHODHMAPTKDM4EKMT2AMEN1
SCHEMBL11894643 0.81 MEN1 (0.37) PARP1NOTUMDHODHMAPTKMT2A
SCHEMBL11894650 0.81 DHODH (0.41) PARP1PKMDHODHMAPTMAPK1
SCHEMBL11894970 0.81 MAPT (0.44) PARP1NOTUMPKMDHODHMAPT
SCHEMBL11904194 0.81 NOTUM (0.37) PARP1NOTUMPKMMAPTKMT2A
SCHEMBL11894960 0.81 DHODH (0.45) DHODHMAPTKDM4EMAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2487175-A1 PHARMACEUTICAL PRODUCT CONTAINING AROMATIC HETEROCYCLIC COMPOUND Kyowa Hakko Kirin Co., Ltd. (JP) 2012-08-15 — — EP disclosed
US-20120196854-A1 PHARMACEUTICAL COMPOSITION COMPRISING AROMATIC HETEROCYCLIC COMPOUND KYOWA HAKKO KIRIN CO., LTD. (JP) 2012-08-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120196854-A1 PHARMACEUTICAL COMPOSITION COMPRISING AROMATIC HETEROCYCLIC COMPOUND CYP2C18, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CYP2B6 PARP1 3986/4885NOTUM 1221/4885PKM 2284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback